Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity

Neurology

Volumn 86, Issue 15, 2016, Pages 1417-1424

  Berrigan, Lindsay I ^a,b   Fisk, John D ^b   Patten, Scott B ^c   Tremlett, Helen ^d   Wolfson, Christina ^e   Warren, Sharon ^f   Fiest, Kirsten M ^g   McKay, Kyla A ^d   Marrie, Ruth Ann ^g  

^a ST FRANCIS XAVIER UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CATARACT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; DISABILITY; DISEASE ASSOCIATION; EPILEPSY; EXPANDED DISABILITY STATUS SCALE; FATIGUE; FATIGUE IMPACT SCALE; FEMALE; FIBROMYALGIA; GLAUCOMA; HEART DISEASE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATORY BOWEL DISEASE; IRRITABLE COLON; LUPUS VULGARIS; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTIPLE SCLEROSIS; OSTEOPOROSIS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; THYROID DISEASE;

EID: 84964886515     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002564     Document Type: Article

References (40)

1. Papuc E, Stelmasiak Z. Factors predicting quality of life in a group of Polish subjects with multiple sclerosis: accounting for functional state, socio-demographic and clinical factors. Clin Neurol Neurosurg 2012;114: 341-346.
2. Hermann B, Vickrey B, Hays RD, et al. A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Res 1996;25: 113-118.
3. Rudick RA, Miller DM, Clough JD, Gragg LA, Farmer RG. Quality of life in multiple sclerosis: comparison with inflammatory bowel disease and rheumatoid arthritis. Arch Neurol 1992;49:1237-1242.
4. Wu N, Minden SL, Hoaglin DC, Hadden L, Frankel D. Quality of life in people with multiple sclerosis: data from the Sonya Slifka Longitudinal Multiple Sclerosis Study. J Health Hum Serv Adm 2007;30:233-267.
5. Marrie RA, Cohen J, Stuve O, et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler 2015;21:263-281.
6. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA. Causes and consequences of comorbidity: a review. J Clin Epidemiol 2001;54: 661-674.
7. Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci 2002;205:51-58.
8. Janssens ACJW, Van Doorn PA, De Boer JB, et al. Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Mult Scler 2003;9:397-403.
9. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
10. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Ann Neurol 2005;58:840-846.
11. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
12. Feeny DH, Furlong W, Torrance GW, et al. Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 system. Med Care 2002;40: 113-128.
13. Fisk JD, Brown MG, Sketris IS, Metz LM, Murray TJ, Stadnyk KJ. A comparison of health utility measures for the evaluation of multiple sclerosis treatments. J Neurol Neurosurg Psychiatry 2005;76:58-63.
14. Horton M, Rudick RA, Hara-Cleaver C, Marrie RA. Validation of a self-report comorbidity questionnaire for multiple sclerosis. Neuroepidemiology 2010;35:83-90.
15. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370.
16. Honarmand K, Feinstein A. Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Mult Scler 2009;15:1518-1524.
17. Fisk JD, Doble SE. Construction and validation of a fatigue impact scale for daily administration (D-FIS). Qual Life Res 2002;11:263.
18. Arbuckle JL. AMOS 20 Users Guide. Chicago: SPSS; 2011.
19. Byrne BM. Structural Equation Modeling With AMOS: Basic Concepts, Applications, and Programming. Mahwah, NJ: Lawrence Erlbaum Associates; 2001.
20. Tabachnick BG, Fidell LS. Using Multivariate Statistics, 5th ed. New York: Pearson Education; 2007.
21. Moffitt TE, Harrington H, Caspi A, et al. Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry 2007;64:651-660.
22. Kline RB. Principles and Practices of Structural Equation Modeling, 2nd ed. New York: The Guilford Press; 2005.
23. Feng Y, Bernier J, McIntosh C, Orpana H. Validation of disability categories derived from Health Utilities Index Mark 3 scores. Health Rep 2009;20:43-50.
24. Turpin KV, Carroll LJ, Cassidy JD, Hader WJ. Deterioration in the health-related quality of life of persons with multiple sclerosis: the possible warning signs. Mult Scler 2007;13:1038-1045.
25. Warren SA, Turpin KV, Pohar SI, Jones CA, Warren KG. Comorbidity and health-related quality of life in people with multiple sclerosis. Int J MS Care 2009;11:6-16.
26. Marrie RA, Horwitz R, Cutter G, Tyry T. Cumulative impact of comorbidity on quality of life in MS. Acta Neurol Scand 2012:125;180-186.
27. Villani V, Prosperini L, Pozzilli C, Salvetti M, Sette G. Quality of life of multiple sclerosis patients with comorbid migraine. Neurol Sci 2011;32(suppl 1):S149-S151.
28. Horsman J, Fulong W, Feeny D, Torrance G. The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes 2003;1:54.
29. Marrie RA, Cutter G, Tyry T, Campagnolo D, Vollmer T. Effect of physical comorbidities on risk of depression in multiple sclerosis. Int J MS Care 2009;11:161-165.
30. Finlayson M, Preissner K, Cho C. Impact of comorbidity on fatigue management intervention outcomes among people with multiple sclerosis. Int J MS Care 2013;15: 21-26.
31. Carta MG, Moro MF, Lorefice L, et al. Multiple sclerosis and bipolar disorders: the burden of comorbidity and its consequences on quality of life. J Affective Disord 2014; 167:192-197.
32. Goldman Consensus Group. The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler 2005;11:328-337.
33. Tepavcevic DK, Pekmezovic T, Stojsavljevic N, et al. Change in quality of life and predictors of change among patients with multiple sclerosis: a prospective cohort study. Qual Life Res 2014;23:1027-1037.
34. Penner IK, Bechtel N, Raselli C, et al. Fatigue in multiple sclerosis: relation to depression, physical impairment, personality and action control. Mult Scler 2007;13: 1161-1167.
35. Dubayova T, Krokavcova M, Nagyova I, et al. Type D, anxiety and depression in association with quality of life in patients with Parkinsons disease and patients with multiple sclerosis. Qual Life Rese 2013;22:1353-1360.
36. Szilasiova J, Krokavcova M, Gdovinova Z, Rosenberger J, Van Dijk JP. Quality of life in patients with multiple sclerosis in Eastern Slovakia. Disabil Rehabil 2011;33: 1587-1593.
37. Motl RW, McAuley E, Snook EM, Gliottoni RC. Physical activity and quality of life in multiple sclerosis: intermediary roles of disability fatigue, mood, pain, selfefficacy and social support. Psychol Health Med 2009; 14:111-124.
38. Poder K, Ghatavi K, Fisk JD, et al. Social anxiety in a multiple sclerosis clinic population. Mult Scler 2009;15: 393-398.
39. Bayliss EA, Ellis JL, Steiner JF. Subjective assessments of comorbidity correlate with quality of life health outcomes: initial validation of a comorbidity assessment instrument. Health Qual Life Outcomes 2005;2:51.
40. Voaklander D, Kelly KD, Jones CA, Suarez-Almazor ME. Self report co-morbidity and health related quality of life: a comparison with record based co-morbidity measures. Soc Indic Res 2004;66:213-228.